HCW Biologics Inc.
HCWB
$4.99
-$0.27-5.06%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 6.54M | 27.00K | 15.60K | 6.60K | 5.10K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.54M | 27.00K | 15.60K | 6.60K | 5.10K |
| Cost of Revenue | 11.10K | 21.60K | 12.50K | 5.20K | 4.10K |
| Gross Profit | 6.53M | 5.40K | 3.10K | 1.30K | 1.00K |
| SG&A Expenses | 1.87M | 3.66M | 1.92M | 2.27M | 2.51M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 198.10K | -- | -- | -- | -- |
| Total Operating Expenses | 3.31M | 4.99M | 3.31M | 3.47M | 3.97M |
| Operating Income | 3.24M | -4.96M | -3.29M | -3.46M | -3.97M |
| Income Before Tax | 3.80M | 719.20K | -4.55M | -1.93M | -2.20M |
| Income Tax Expenses | 330.20K | -- | -- | -- | -- |
| Earnings from Continuing Operations | 3.47M | 719.20K | -4.55M | -1.93M | -2.20M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3.47M | 719.20K | -4.55M | -1.93M | -2.20M |
| EBIT | 3.24M | -4.96M | -3.29M | -3.46M | -3.97M |
| EBITDA | 3.38M | -4.80M | -3.12M | -3.17M | -3.55M |
| EPS Basic | 2.19 | -6.15 | -12.09 | -40.72 | -11.80 |
| Normalized Basic EPS | 2.63 | -5.81 | -5.95 | -7.74 | -14.09 |
| EPS Diluted | 2.19 | -6.15 | -12.09 | -40.72 | -11.80 |
| Normalized Diluted EPS | 2.63 | -5.81 | -5.95 | -7.74 | -14.09 |
| Average Basic Shares Outstanding | 904.30K | 564.00K | 376.70K | 296.70K | 186.10K |
| Average Diluted Shares Outstanding | 904.30K | 564.00K | 376.70K | 296.70K | 186.10K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |